Rhythm Pharmaceuticals, Inc. (RYTM) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Rhythm Pharmaceuticals Inc RYTM
$87.81
▲ +1.12%
(+$0.97)
Open
$87.04
Prev Close
$86.84
Day Range
$84.90 – $88.50
52W Range
$58.71 – $122.20
Market Cap
$5.95B
Beta
1.94
EPS (TTM)
$-3.06
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2017-10-05 |
| Shares Out. | 68,290,000 |
| Website | rhythmtx.com/ ↗ |
| Phone | 18009279800 |
Rhythm Pharmaceuticals Inc is a publicly traded company under the ticker symbol RYTM on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
22 analysts (2026-05-01)
📰 Latest News for RYTM
Transcript : Rhythm Pharmaceuticals, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-13-2026 03
Rhythm Pharmaceuticals Announces New Data Presentations at the 2026 European Congress of Endocrinology
Rhythm Pharmaceuticals, Inc. 2026 Q1 - Results - Earnings Call Presentation
Canaccord Genuity Maintains Buy on Rhythm Pharmaceuticals, Raises Price Target to $143
Rhythm Pharmaceuticals Analysts Boost Their Forecasts Following Upbeat Q1 Results
RBC Capital Maintains Outperform on Rhythm Pharmaceuticals, Raises Price Target to $137
Wells Fargo Maintains Overweight on Rhythm Pharmaceuticals, Raises Price Target to $144